Zhejiang ACEA Pharmaceutical Co. Ltd.

7 clinical trials · Sponsor

Record	Firm	Date
A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML) (NCT05947344)	Zhejiang ACEA Pharmaceutical Co. Ltd.	2023-12-08
A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese Subjects (NCT06044233)	Zhejiang ACEA Pharmaceutical Co. Ltd.	2023-09-28
[14C] Study on Mass Balance and Biotransformation of STI-1558 in Healthy Chinese Adult Male Subjects (NCT05754411)	Zhejiang ACEA Pharmaceutical Co. Ltd.	2023-05-15
Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma (NCT05565807)	Zhejiang ACEA Pharmaceutical Co. Ltd.	2023-02-09
Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19) (NCT05716425)	Zhejiang ACEA Pharmaceutical Co. Ltd.	2023-02-08
A Study to Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558 (NCT05685719)	Zhejiang ACEA Pharmaceutical Co. Ltd.	2023-01-04
Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients (NCT05523739)	Zhejiang ACEA Pharmaceutical Co. Ltd.	2022-09-16

Every clearance here is in the API, with alerts when new ones post.